ENXTAM:ABN
ENXTAM:ABNBanks

Is ABN AMRO (ENXTAM:ABN) Facing a Prolonged Margin Squeeze Amid Consistent Earnings Pressure?

ABN AMRO Bank N.V. recently reported its earnings for the third quarter and first nine months of 2025, disclosing a decrease in both net interest income and net income compared to the prior year. This marks a consecutive period of lower basic earnings per share from continuing operations, signaling ongoing pressure on the bank’s profitability. We’ll explore how this continued earnings decline sharpens questions around ABN AMRO’s future profitability and margin sustainability. These 12...
ENXTAM:OCI
ENXTAM:OCIChemicals

3 Promising European Penny Stocks With Market Caps Up To €2B

Amid renewed concerns about inflated AI stock valuations and receding expectations for a U.S. interest rate cut, European markets have faced downward pressure, with major indices like the STOXX Europe 600 Index ending lower. Despite these challenges, investors continue to seek opportunities in smaller or newer companies that can offer growth potential at accessible price points. Penny stocks, though an older term, remain relevant as they represent a chance to invest in companies with strong...
ENXTAM:AKZA
ENXTAM:AKZAChemicals

Akzo Nobel (ENXTAM:AKZA): Assessing Valuation After Recent Share Price Weakness

Akzo Nobel (ENXTAM:AKZA) shares have posted a slight decline over the past month, catching the eye of investors who watch the company’s performance closely. With market sentiment turning cautious, there is interest in what comes next. See our latest analysis for Akzo Nobel. Zooming out, Akzo Nobel's 1-month share price return of -11.1% extends the downtrend seen throughout the year. The stock now shows a -0.2% one-year total shareholder return. Momentum has clearly faded, as recent caution...
ENXTAM:PHARM
ENXTAM:PHARMBiotechs

Pharming Group (ENXTAM:PHARM): Valuation Insights Following Raised 2025 Outlook and Strong Earnings Momentum

Pharming Group (ENXTAM:PHARM) just raised its revenue outlook for 2025 following an impressive earnings update, with sales up sharply and net loss narrowing year-over-year. Investors are taking note of this renewed momentum. See our latest analysis for Pharming Group. With a 44.7% year-to-date share price return and a striking 98% total shareholder return over the past year, Pharming Group’s strong results and refreshed leadership are building real momentum. Investors are rewarding the...
ENXTAM:INPST
ENXTAM:INPSTLogistics

Can InPost's (ENXTAM:INPST) Bold Growth Targets Outweigh the Pressure on Profitability?

InPost S.A. recently reported its third-quarter 2025 financial results, showing sales of PLN 3,768.9 million and net income of PLN 170.7 million, alongside a reaffirmed full-year earnings outlook with expected volume growth of 25%–30% and revenue growth of 35%–40%. While the company posted substantial year-over-year revenue growth, profitability decreased, highlighting ongoing challenges despite management's confidence in maintaining ambitious guidance targets. We'll explore how InPost's...
ENXTAM:SBMO
ENXTAM:SBMOEnergy Services

SBM Offshore (ENXTAM:SBMO): Assessing Valuation After Strong Year-to-Date Share Price Gains

SBM Offshore (ENXTAM:SBMO) shares have drawn attention this month, rising alongside steady gains in the energy sector. Investors are taking notice as the company posts healthy returns and shows solid year-to-date performance. See our latest analysis for SBM Offshore. SBM Offshore’s latest surge comes after a steady climb this year, with the share price up 44.8% year-to-date and achieving a robust 49.1% total shareholder return over the past twelve months. Momentum appears strong, building off...
ENXTAM:FUR
ENXTAM:FURConstruction

Fugro (ENXTAM:FUR) Valuation in Focus Following Q3 2025 Sales and Trading Statement Release

Fugro (ENXTAM:FUR) drew market attention following its Q3 2025 sales and trading statement call on October 31. This routine event often provides investors with fresh insights into company performance and outlook. See our latest analysis for Fugro. While Fugro’s Q3 update has stirred fresh interest, the company’s momentum remains challenged, with a year-to-date share price return of -49.27% and a one-year total shareholder return of -42.55%. Despite some short-term upticks, longer-term...
ENXTAM:BNJ
ENXTAM:BNJEntertainment

Do Delayed Revenues at Banijay Group (ENXTAM:BNJ) Reveal a Shift in Long-Term Growth Focus?

Banijay Group N.V. recently reported its earnings for the nine months ended September 30, 2025, showing sales of €3.22 billion and net income of €118.7 million, along with an update on annual guidance pointing to low-single digit growth in Entertainment & Live and around 10% growth at Banijay Gaming following a temporary hit from adverse sports results. An important detail emerging from these announcements is the company's decision to postpone some content deliveries to early 2026, paired...